5 Key Takeaways

• 1

  The American College of Cardiology calls for universal screening of high-sensitivity C-reactive protein in cardiovascular disease prevention.

• 2

  Residual inflammatory risk, indicated by elevated hsCRP, predicts recurrent cardiovascular events even in optimally treated patients.

• 3

  In statin-treated patients, hsCRP is a stronger predictor of recurrent myocardial infarction and cardiovascular death than LDL cholesterol.

• 4

  The statement provides clinical thresholds for hsCRP levels to assess cardiovascular risk, with specific actions recommended based on these levels.

• 5

  Colchicine shows efficacy in reducing recurrent cardiovascular events, but its use remains low despite evidence supporting its safety and effectiveness.